Entries by CAPTIS

Novartis gets EC nod for Cosentyx drug in paediatric psoriasis

Psoriasis, a life-long systemic inflammatory disease, is said to significantly affect the patients’ quality of life, both physically and emotionally. Cosentyx is claimed to be the first and The post Novartis gets EC nod for Cosentyx drug in paediatric psoriasis appeared first on Pharmaceutical Business review.

Pfizer says Covid-19 vaccine may be needed regularly

Evidence has not emerged yet on how long coronavirus antibodies could protect against the disease, noted Bloomberg. Also, data from early trials have not demonstrated that a vaccine The post Pfizer says Covid-19 vaccine may be needed regularly appeared first on Pharmaceutical Business review.

SAB Biotherapeutics announces first participant dosed in phase 1 clinical trial of SAB-176 for seasonal influenza

SAB-176 is a novel anti-influenza human immunoglobulin G (IgG) immunotherapy designed to address the limitations of current treatment for severe seasonal influenza. This fully human polyclonal antibody therapeutic The post SAB Biotherapeutics announces first participant dosed in phase 1 clinical trial of SAB-176 for seasonal influenza appeared first on Pharmaceutical Business review.